RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--PharmaLinkFHI, Inc. (PharmaLink) announced today the acquisition of Matrix Contract Research, LTD, a UK-based Clinical Research Organization (CRO) and flexible clinical staffing company. “After several years of robust growth, it was critical for PharmaLink to expand its clinical reach and client service offerings and become a global company,” says Richard Staub, President and Chief Executive Officer. Mr. Staub continues, “The integration of Matrix with PharmaLink’s unique eClinical service delivery model will allow us jointly to better serve our clients who require development services throughout the North America, Western, Central, and Eastern Europe including Russia.”
